- List
- By Topic
- On Map
- Search Details

Pituitary Tumors
Need help? See RSS Feeds
Choose a feed type:

Pituitary Tumors (155 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
101 | NCT00002947 | Terminated | Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer |
|
|
Interventional | Phase 1 |
|
Other / NIH |
|
35 | All | 18 Years and older (Adult, Senior) | NCT00002947 | CDR0000065414 YALE-HIC-9041 NCI-G97-1154 |
October 1996 | August 2004 | August 2004 | March 26, 2004 | July 2, 2014 |
|
|||
102 | NCT02727686 | Recruiting | Post-Operative Water Load Following Transsphenoidal Pituitary Surgery |
|
|
Interventional | Not Applicable |
|
Other |
|
|
15 | All | 18 Years to 80 Years (Adult, Senior) | NCT02727686 | PHX1600103012 | April 2016 | December 2017 | January 2018 | April 5, 2016 | October 12, 2016 |
|
||
103 | NCT02803697 | Recruiting | Predictive Factors of Recurrence of Non Functioning Pituitary Adenomas : a Retrospective Study of 220 Patients in the Reims University Hospital, France |
|
|
Observational |
|
Other |
|
|
220 | All | 18 Years and older (Adult, Senior) | NCT02803697 | PA13045 | November 2015 | March 2017 | November 2017 | June 17, 2016 | December 28, 2016 |
|
|||
104 | NCT00383708 | Completed | Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
125 | All | 18 Years to 75 Years (Adult, Senior) | NCT00383708 | 2-55-52030-727 | October 2006 | October 2008 | October 2008 | October 3, 2006 | June 19, 2012 |
|
||
105 | NCT02574793 | Completed | Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects |
|
|
Observational |
|
Other |
|
|
60 | All | Child, Adult, Senior | NCT02574793 | KY2015-152 | December 1, 2014 | December 31, 2017 | January 7, 2018 | October 14, 2015 | January 23, 2018 |
|
|||
106 | NCT02834013 | Recruiting | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
707 | All | 18 Years and older (Adult, Senior) | NCT02834013 | NCI-2016-01041 S1609 U10CA180888 |
January 13, 2017 | August 31, 2020 | July 15, 2016 | April 24, 2018 |
|
|||
107 | NCT00973557 | Completed | The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function |
|
Observational |
|
Other |
|
|
6 | All | 18 Years and older (Adult, Senior) | NCT00973557 | Pro00019830 | September 2009 | September 2011 | January 2012 | September 9, 2009 | February 7, 2012 |
|
||||
108 | NCT02160730 | Recruiting | Treatment of Cushing's Disease With R-roscovitine |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
16 | All | 18 Years and older (Adult, Senior) | NCT02160730 | Pro35720 1R21DK103198-01 |
May 2014 | December 2018 | December 2019 | June 11, 2014 | January 29, 2018 |
|
||
109 | NCT03382158 | Recruiting | International PPB Registry for PPB, DICER1 and Associated Conditions |
|
Observational |
|
Other |
|
|
100 | All | Child, Adult, Senior | NCT03382158 | FDAAA | December 6, 2016 | December 6, 2023 | December 6, 2026 | December 22, 2017 | December 22, 2017 |
|
||||
110 | NCT02484755 | Unknown † | Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease |
|
|
Interventional | Phase 2 |
|
Other |
|
|
6 | All | 18 Years to 70 Years (Adult, Senior) | NCT02484755 | KY2015-167 | June 2015 | September 2015 | June 30, 2015 | June 30, 2015 |
|
|||
111 | NCT02536261 | Recruiting | Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus |
|
Observational |
|
Other |
|
|
30 | All | 15 Years to 70 Years (Child, Adult, Senior) | NCT02536261 | WSIP-1586 | June 2016 | December 2019 | August 31, 2015 | May 16, 2017 |
|
|||||
112 | NCT01444209 | Recruiting | Radioactive Iodine Implants for Pan-invasive Pituitary Macroadenomas |
|
|
Interventional | Phase 2 |
|
Other |
|
|
24 | All | 18 Years to 99 Years (Adult, Senior) | NCT01444209 | STU 042011-075 | October 2011 | December 2017 | December 2020 | September 30, 2011 | January 9, 2017 |
|
||
113 | NCT02233335 | Completed | The Factors Associated With the Recurrence in Patients With Cushing Disease |
|
Observational |
|
Other |
|
|
42 | All | Child, Adult, Senior | NCT02233335 | 201305026RINC | June 2013 | May 2014 | May 2014 | September 8, 2014 | September 8, 2014 |
|
||||
114 | NCT03364803 | Recruiting | Collecting Information About Treatment Results for Patients With Cushing's Syndrome |
|
|
Observational |
|
Other |
|
|
200 | All | 14 Years and older (Child, Adult, Senior) | NCT03364803 | 17-592 | November 28, 2017 | November 28, 2024 | November 28, 2024 | December 7, 2017 | March 15, 2018 |
|
|||
115 | NCT03400865 | Not yet recruiting | Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | All | 18 Years to 70 Years (Adult, Senior) | NCT03400865 | HCCT-2018 | February 25, 2018 | December 30, 2020 | December 30, 2020 | January 17, 2018 | January 17, 2018 |
|
||
116 | NCT02637479 | Recruiting | Treatment of Opioid-refractory Pain (WHO Level III) by Pituitary Radiosurgery |
|
|
Interventional | Not Applicable |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT02637479 | 2014-51 2015-A00616-43 RCAPHM15_0022 |
Hyporadoul | December 2015 | December 2018 | December 2018 | December 22, 2015 | December 22, 2015 |
|
|
117 | NCT01143584 | Unknown † | Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas. |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | All | Child, Adult, Senior | NCT01143584 | prlcab2020 | May 2010 | December 2011 | March 2012 | June 14, 2010 | June 14, 2010 |
|
||
118 | NCT03038308 | Recruiting | Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole |
|
|
Interventional | Phase 1 Phase 2 |
|
Other / NIH |
|
|
26 | All | 18 Years to 70 Years (Adult, Senior) | NCT03038308 | AAAI8604 1R21DK112093-01 |
September 16, 2016 | July 1, 2019 | July 1, 2019 | January 31, 2017 | January 31, 2017 |
|
||
119 | NCT02310269 | Recruiting | Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease |
|
|
Observational |
|
Industry |
|
|
200 | All | 18 Years and older (Adult, Senior) | NCT02310269 | CSOM230B2410 | March 28, 2013 | May 14, 2024 | May 14, 2024 | December 8, 2014 | March 6, 2018 |
|
|||
120 | NCT02350153 | Active, not recruiting | Cushing´s Disease Epidemiology in Sweden |
|
Observational |
|
Other |
|
|
400 | All | 18 Years and older (Adult, Senior) | NCT02350153 | NSSCDIO | September 2013 | May 2018 | September 2018 | January 29, 2015 | August 24, 2017 |
|
||||
121 | NCT02697734 | Recruiting | Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
69 | All | 18 Years to 75 Years (Adult, Senior) | NCT02697734 | CLCI699C2302 | LINC-4 | October 3, 2016 | October 25, 2019 | October 25, 2019 | March 3, 2016 | November 14, 2017 |
|
|
122 | NCT03297892 | Not yet recruiting | Health Status of the Patients Followed for a Disease of Cushing in the Region Large-West of 1990 to 2015 |
|
Observational |
|
Other |
|
|
60 | All | 18 Years and older (Adult, Senior) | NCT03297892 | CUSHING RB (15.217) | CUSHING | October 2017 | March 2018 | March 2018 | September 29, 2017 | October 5, 2017 | ||||
123 | NCT00434148 | Completed Has Results |
Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
162 | All | 18 Years and older (Adult, Senior) | NCT00434148 | CSOM230B2305 2006-004111-22 |
December 2006 | March 2010 | May 2014 | February 12, 2007 | March 8, 2016 | February 6, 2013 |
|
|
124 | NCT02568982 | Recruiting | Cushing's Disease Complications |
|
|
Observational |
|
Other |
|
|
150 | All | 18 Years and older (Adult, Senior) | NCT02568982 | P120132 | COMPLICUSHING | September 21, 2015 | March 2020 | September 2020 | October 6, 2015 | March 19, 2018 |
|
||
125 | NCT02180217 | Active, not recruiting | Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
137 | All | 18 Years and older (Adult, Senior) | NCT02180217 | CLCI699C2301 2013-004766-34 |
October 6, 2014 | March 23, 2018 | December 7, 2018 | July 2, 2014 | October 18, 2017 |
|
||
126 | NCT03353025 | Recruiting | Study on Therapy of Non-invasive Prolactinoma |
|
|
Interventional | Not Applicable |
|
Other |
|
|
394 | All | 18 Years to 60 Years (Adult) | NCT03353025 | 2016008 | TNAPA | January 1, 2016 | December 31, 2025 | December 31, 2025 | November 24, 2017 | November 24, 2017 |
|
|
127 | NCT03080181 | Completed | Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment |
|
|
Interventional | Phase 4 |
|
Other |
|
|
24 | All | 18 Years and older (Adult, Senior) | NCT03080181 | Pasireotide-CD | May 2013 | December 30, 2016 | January 28, 2017 | March 15, 2017 | October 27, 2017 | |||
128 | NCT03111810 | Recruiting | Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
32 | Male | 18 Years to 60 Years (Adult) | NCT03111810 | 212634 | TICSI | May 25, 2017 | December 2018 | January 2019 | April 13, 2017 | October 6, 2017 |
|
|
129 | NCT01374906 | Completed Has Results |
Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
150 | All | 18 Years and older (Adult, Senior) | NCT01374906 | CSOM230G2304 2009-011128-70 |
November 4, 2011 | December 21, 2016 | December 21, 2016 | June 16, 2011 | April 11, 2018 | April 11, 2018 |
|
|
130 | NCT02603653 | Unknown † | Assessment of Persistent Cognitive Impairment After Cure of Cushing's Disease |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | All | 18 Years to 60 Years (Adult) | NCT02603653 | C15-02 IDRCB |
MEMOCUSH | November 2015 | May 2016 | May 2017 | November 13, 2015 | November 13, 2015 |
|
|
131 | NCT00521300 | Completed | Preoperative Octreotide Treatment of Acromegaly |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
62 | All | 18 Years to 80 Years (Adult, Senior) | NCT00521300 | S-71-98 (REK) S-71-98 SLKNR 98-5560 |
POTA | September 1999 | June 2005 | May 2010 | August 27, 2007 | June 2, 2014 |
|
|
132 | NCT01925092 | Withdrawn | Mifepristone in Children With Refractory Cushing's Disease |
|
|
Interventional | Phase 3 |
|
Industry / NIH |
|
|
0 | All | 6 Years to 17 Years (Child) | NCT01925092 | 13-CH-0170 02811-12 |
August 2013 | December 2016 | August 19, 2013 | August 4, 2014 |
|
|||
133 | NCT01331239 | Active, not recruiting | Safety and Efficacy of LCI699 in Cushing's Disease Patients. |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
33 | All | 18 Years to 75 Years (Adult, Senior) | NCT01331239 | CLCI699C2201 2010-022403-22 |
March 23, 2011 | December 21, 2018 | December 21, 2018 | April 8, 2011 | October 16, 2017 |
|
||
134 | NCT02060383 | Recruiting | Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
246 | All | 18 Years and older (Adult, Senior) | NCT02060383 | CSOM230B2219 2012-002916-16 |
May 23, 2014 | April 13, 2018 | April 13, 2018 | February 12, 2014 | February 2, 2018 |
|
||
135 | NCT00088608 | Completed | A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
26 | All | 18 Years to 80 Years (Adult, Senior) | NCT00088608 | CSOM230B2208 | April 2004 | June 2006 | August 2, 2004 | November 7, 2016 |
|
|||
136 | NCT01371565 | Completed Has Results |
Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
4 | All | 18 Years and older (Adult, Senior) | NCT01371565 | C1073-405 | November 2010 | June 2012 | September 2012 | June 13, 2011 | March 18, 2014 | November 20, 2013 |
|
|
137 | NCT02081768 | Recruiting | 90Yttrium Colloid for the Treatment of Cystic Sellar/Parasellar Tumors |
|
|
Interventional | Phase 3 |
|
Other |
|
|
40 | All | 17 Years and older (Child, Adult, Senior) | NCT02081768 | Yttrium2014 | June 2014 | June 2024 | June 2025 | March 7, 2014 | April 20, 2017 |
|
||
138 | NCT00460616 | Completed | Cardiac Valve Complications in Prolactinomas Treated With Cabergoline |
|
|
Observational |
|
Other |
|
|
50 | All | 18 Years to 65 Years (Adult) | NCT00460616 | NeuroendoUnit-2 | ValveCab | January 2007 | September 2007 | April 16, 2007 | April 16, 2008 |
|
|||
139 | NCT00697814 | Completed | Clomiphene in Males With Prolactinomas and Persistent Hypogonadism |
|
|
Interventional | Phase 2 |
|
Other |
|
|
15 | Male | 18 Years to 70 Years (Adult, Senior) | NCT00697814 | 1374/04 | June 2004 | June 2005 | June 2005 | June 16, 2008 | June 16, 2008 |
|
||
140 | NCT00881283 | Terminated | Long-term Cardiovascular Risk in Cured Cushing's Patients |
|
Observational |
|
Other |
|
|
1 | Female | 35 Years to 55 Years (Adult) | NCT00881283 | 2008-p-001379 | September 8, 2008 | March 30, 2010 | March 30, 2010 | April 15, 2009 | January 20, 2017 |
|
||||
141 | NCT00171951 | Completed | Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushing's Disease |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
19 | All | 18 Years and older (Adult, Senior) | NCT00171951 | CSOM230B2208E1 2004-002407-32 |
August 2004 | July 2013 | July 2013 | September 15, 2005 | November 16, 2016 |
|
||
142 | NCT00845351 | Unknown † | Preoperative Bexarotene Treatment for Cushing's Disease |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
6 | All | 18 Years to 65 Years (Adult) | NCT00845351 | 13936 | November 2008 | December 2011 | December 2011 | February 18, 2009 | May 30, 2011 |
|
||
143 | NCT00481299 | Completed | Insulin Resistance in Women With Prolactinoma |
|
Observational |
|
Other |
|
2004 | Female | 18 Years to 48 Years (Adult) | NCT00481299 | 178/04 | October 2004 | September 2006 | June 1, 2007 | June 1, 2007 |
|
||||||
144 | NCT00081341 | Completed | Cognition, Steroids, and Imaging in Cushings Disease |
|
Observational |
|
NIH |
|
All | 9 Years and older (Child, Adult, Senior) | NCT00081341 | 51337DK (completed) | December 2002 | April 12, 2004 | February 15, 2010 |
|
||||||||
145 | NCT02792582 | Recruiting | A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection |
|
|
Interventional | Phase 2 |
|
Other |
|
|
140 | All | up to 21 Years (Child, Adult) | NCT02792582 | RT3CR NCI-2016-00813 |
June 22, 2016 | June 2025 | June 2027 | June 7, 2016 | September 28, 2017 |
|
||
146 | NCT00934271 | Completed | Fractionated Stereotactic Radiotherapy in Patients With Acromegaly |
|
|
Observational |
|
Other |
|
|
34 | All | 18 Years and older (Adult, Senior) | NCT00934271 | FSRT-SR-UFR | January 2002 | January 2008 | January 2008 | July 8, 2009 | October 28, 2014 |
|
|||
147 | NCT03348501 | Recruiting | Study and Follow-up of Multiple Endocrine Neoplasia Type 1 |
|
|
Observational |
|
Other |
|
|
2000 | All | Child, Adult, Senior | NCT03348501 | GOUDET PARI2011 | GENEM | July 2012 | July 2031 | July 2031 | November 21, 2017 | November 21, 2017 |
|
||
148 | NCT03137615 | Completed | The Cardiovascular Changes Associated With Septal Local Anaesthesia |
|
|
Observational |
|
Other |
|
|
15 | All | 17 Years and older (Child, Adult, Senior) | NCT03137615 | STH17059 | November 2014 | June 2015 | June 2015 | May 3, 2017 | May 3, 2017 | ||||
149 | NCT01403324 | Terminated | Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer |
|
|
Interventional | Not Applicable |
|
Other |
|
|
4 | All | 18 Years and older (Adult, Senior) | NCT01403324 | DOSIMETA IGR2010/1645 | DOSIMETA | September 2011 | June 2016 | June 2016 | July 27, 2011 | July 13, 2016 |
|
|
150 | NCT03262129 | Recruiting | Type 1 Multiple Endocrine Neoplasia Cohort Study |
|
Observational |
|
Other |
|
|
2000 | All | Child, Adult, Senior | NCT03262129 | GOUDET PARI 2011 | MEN1-GTEcohort | January 1, 2012 | January 2020 | December 2020 | August 25, 2017 | August 25, 2017 |
|
† Study has passed its completion date and status has not been verified in more than two years.